These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 4542687

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Cardiovascular effects of Trasylol in hemorrhagic shock].
    Suzuki K, Kubota M, Namiji T, Kudo K, Odashiro M.
    Masui; 1972 Feb; 21(2):132-7. PubMed ID: 4537244
    [No Abstract] [Full Text] [Related]

  • 4. [Modification of plasma enzyme levels in experimental hemorrhagic shock due to trasylol].
    Horpácsy G, Barankay T, Nagy S, Szabó I, Benló K.
    Med Welt; 1973 Mar 23; 24(12):459-61. PubMed ID: 4540731
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of the proteinase inhibitor aprotinin in the management of hemorrhagic shock in the dog.
    Bottoms GD, Coppoc GL, Roesel OF, Wilcock B, Weirich W.
    Am J Vet Res; 1978 Jun 23; 39(6):1023-6. PubMed ID: 307350
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The protective effect of phosphatidylcholine liposomes in hemorrhagic shock in cats].
    Kryzhanovskiĭ GN, Leskova GF, Udovichenko VI, Kulikova OS.
    Biull Eksp Biol Med; 1995 May 23; 119(5):480-4. PubMed ID: 7579238
    [No Abstract] [Full Text] [Related]

  • 10. Protective effect of thoracic lymph diversion in hemorrhagic shock.
    Glenn TM, Lefer AM.
    Am J Physiol; 1970 Nov 23; 219(5):1305-10. PubMed ID: 5473114
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of experimental hemorrhagic shock with a protease inhibitor: aprotinin].
    Serrano JJ, Uccelli G, Liutkus M, Boucard M.
    Therapie; 1979 Nov 23; 34(1):103-110. PubMed ID: 314684
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A protease inhibitor and reversibility of hemorrhagic shock].
    Dall'Antonia F.
    Acta Chir Ital; 1968 Nov 23; 24 Suppl():553-62. PubMed ID: 5309753
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock.
    Lefer AM.
    Prog Clin Biol Res; 1983 Nov 23; 111():111-23. PubMed ID: 6191336
    [No Abstract] [Full Text] [Related]

  • 16. Humoral factors in shock causing bradycardia and myocardial depression.
    David D, Hilewitz H, Rogel S.
    Circ Shock; 1977 Nov 23; 4(2):153-61. PubMed ID: 21757
    [Abstract] [Full Text] [Related]

  • 17. [Proteinase inhibitor and the liver in shock. Experimental and ultrastructural study].
    Mallet-Guy P, Mallet-Guy Y, Switalska C, Botev S.
    Bull Soc Int Chir; 1972 Nov 23; 31(5):473-80. PubMed ID: 4540273
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.